Larvol Delta - Icovamenib-Treatment-in-Patients-with-Severe-InsulinDecient-Diabetes-Led-to-a-Signicant-Improvement-in-Pancreatic-Betacell-Function-with-a-53-Mean-Increase-in-Cpeptide-Levels-3-Months-After-Last-Dose

icovamenib (BMF-219) - Biomea Fusion

https://www.globenewswire.com/news-release/2025/03/24/3047842/0/en/Icovamenib-Treatment-in-Patients-with-Severe-Insulin-Deficient-Diabetes-Led-to-a-Significant-Improvement-in-Pancreatic-Beta-cell-Function-with-a-53-Mean-Increase-in-C-peptide-Level.html

Mar 24, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next